Literature DB >> 25511188

Skin cancer. Golden age of melanoma therapy.

Lisa Hutchinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25511188     DOI： 10.1038/nrclinonc.2014.219

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Nivolumab in previously untreated melanoma without BRAF mutation.

Authors:  Caroline Robert; Georgina V Long; Benjamin Brady; Caroline Dutriaux; Michele Maio; Laurent Mortier; Jessica C Hassel; Piotr Rutkowski; Catriona McNeil; Ewa Kalinka-Warzocha; Kerry J Savage; Micaela M Hernberg; Celeste Lebbé; Julie Charles; Catalin Mihalcioiu; Vanna Chiarion-Sileni; Cornelia Mauch; Francesco Cognetti; Ana Arance; Henrik Schmidt; Dirk Schadendorf; Helen Gogas; Lotta Lundgren-Eriksson; Christine Horak; Brian Sharkey; Ian M Waxman; Victoria Atkinson; Paolo A Ascierto
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Improved overall survival in melanoma with combined dabrafenib and trametinib.

Authors:  Caroline Robert; Boguslawa Karaszewska; Jacob Schachter; Piotr Rutkowski; Andrzej Mackiewicz; Daniil Stroiakovski; Michael Lichinitser; Reinhard Dummer; Florent Grange; Laurent Mortier; Vanna Chiarion-Sileni; Kamil Drucis; Ivana Krajsova; Axel Hauschild; Paul Lorigan; Pascal Wolter; Georgina V Long; Keith Flaherty; Paul Nathan; Antoni Ribas; Anne-Marie Martin; Peng Sun; Wendy Crist; Jeff Legos; Stephen D Rubin; Shonda M Little; Dirk Schadendorf
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245
  2 in total
  5 in total

1.  Compound 13, an α1-selective small molecule activator of AMPK, potently inhibits melanoma cell proliferation.

Authors:  Xueqing Hu; Fangzhen Jiang; Qi Bao; Huan Qian; Quan Fang; Zheren Shao
Journal:  Tumour Biol       Date:  2015-08-14

2.  VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo.

Authors:  Zheren Shao; Qi Bao; Fangzhen Jiang; Huan Qian; Quan Fang; Xueqing Hu
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

3.  Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells.

Authors:  Fangzhen Jiang; Kai Jin; Shenyu Huang; Qi Bao; Zheren Shao; Xueqing Hu; Juan Ye
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

Review 4.  Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.

Authors:  Jean Christopher Chamcheu; Tithi Roy; Mohammad Burhan Uddin; Sergette Banang-Mbeumi; Roxane-Cherille N Chamcheu; Anthony L Walker; Yong-Yu Liu; Shile Huang
Journal:  Cells       Date:  2019-07-31       Impact factor: 6.600

5.  Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas.

Authors:  R Ellis; D Tang; B Nasr; A Greenwood; A McConnell; M E Anagnostou; M Elias; S Verykiou; D Bajwa; T Ewen; N J Reynolds; P Barrett; E Carling; G Watson; J Armstrong; A J Allen; S Horswell; M Labus; P E Lovat
Journal:  Br J Dermatol       Date:  2019-06-19       Impact factor: 9.302
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.